My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Petronet LNG rises on brokerage buy call
Dec 27,2016

Meanwhile, the S&P BSE Sensex was up 128.62 points or 0.5% at 25,935.72.

On the BSE, 42,000 shares were traded on the counter so far as against the average daily volumes of 1.33 lakh shares in the past one quarter. The stock had hit a high of Rs 354.40 and a low of Rs 348.55 so far during the day.

The stock had hit a record high of Rs 410.85 on 17 October 2016 and a 52-week low of Rs 230 on 25 February 2016. It had underperformed the market over the past one month till 26 December 2016, sliding 7.19% compared with the Sensexs 1.94% fall. The scrip had, however, outperformed the market in past one quarter, advancing 0.51% as against the Sensexs 8.79% fall.

The large-cap company has equity capital of Rs 750 crore. Face value per share is Rs 10.

Petronet LNGs net profit rose 81.7% to Rs 459.56 crore on 12.6% decline in net sales to Rs 6338.51 crore in Q2 September 2016 over Q2 September 2015.

Petronet LNG was formed as a joint venture by the Government of India to import liquified natural gas (LNG) and set up LNG terminals in the country.

Powered by Capital Market - Live News

Godrej Properties gains after Godrej BKC receives LEED Platinum certification
Dec 27,2016

The announcement was made during trading hours today, 27 December 2016.

Meanwhile, the BSE Sensex was up 108.36 points, or 0.42%, to 25,915.46.

On the BSE, so far 3,226 shares were traded in the counter, compared with average daily volumes of 33,678 shares in the past one quarter. The stock had hit a high of Rs 298 and a low of Rs 292.05 so far during the day.

The stock hit a 52-week high of Rs 386 on 9 August 2016. The stock hit a 52-week low of Rs 266.40 on 29 February 2016. The stock had underperformed the market over the past 30 days till 26 December 2016, falling 4.96% compared with the 1.94% fall in the Sensex. The scrip had also underperformed the market in past one quarter, falling 12.60% as against Sensexs 8.56% decline.

The mid-cap company has equity capital of Rs 108.18 crore. Face value per share is Rs 5.

Godrej Properties (GPL) announced that Godrej BKC, its commercial project in Mumbai, has received the Leadership in Energy and Environmental Design (LEED) Platinum certification. LEED Platinum certification is globally recognized the highest rating for sustainable buildings. With this achievement, Godrej BKC becomes the only multi-occupant building in Bandra Kurla Complex (BKC), Mumbais new commercial center, to be LEED Platinum certified.

At 1.2 lakh square metres (1 3 million square feet), Godrej BKC n++s one of the largest luxury commercial projects n++n Mumban++. The building received its occupation certificate in May 2016.

On a consolidated basis, net profit of Godrej Properties declined 77.40% to Rs 23.48 crore on 76.59% decline in net sales to Rs 305.60 crore in Q2 September 2016 over Q2 September 2015.

Godrej Properties is currently developing residential, commercial and township projects spread across approximately 11.98 million square meters (129 million square feet) in 12 cities.

Powered by Capital Market - Live News

Cipla gains as foreign brokerage maintains buy rating
Dec 27,2016

Meanwhile, the S&P BSE Sensex was up 110.30 points or 0.43% at 25,917.40.

On the BSE, 51,000 shares were traded on the counter so far as against the average daily volumes of 1.37 lakh shares in the past one quarter. The stock had hit a high of Rs 565.65 and a low of Rs 553.95 so far during the day.

The stock had hit a 52-week high of Rs 660 on 29 December 2015 and a 52-week low of Rs 458.25 on 25 May 2016. It had outperformed the market over the past one month till 26 December 2016, sliding 1.67% compared with the Sensexs 1.94% fall. The scrip had also outperformed the market in past one quarter, declining 8.32% as against the Sensexs 8.79% fall.

The large-cap company has equity capital of Rs 160.88 crore. Face value per share is Rs 2.

On a consolidated basis, Ciplas net profit dropped 34.7% to Rs 354.34 crore on 8.7% rise in net sales to Rs 3671.88 crore in Q2 September 2016 over Q2 September 2015.

Cipla is a global pharmaceutical company. Its portfolio includes over 1,000 products across wide range of therapeutic categories with one quality standard globally.

Powered by Capital Market - Live News

Capital First gains on fund raising plans
Dec 27,2016

The announcement was made after market hours yesterday, 26 December 2016.

Meanwhile, the S&P BSE Sensex was up 68.50 points or 0.27% at 25,875.60.

On the BSE, 3,887 shares were traded on the counter so far as against the average daily volumes of 38,727 shares in the past one quarter. The stock was volatile. The stock rose as much as 1.79% at the days high of Rs 522.95 so far during the day. The stock rose as much as 0.03% at the days low of Rs 513.90 so far during the day.

The stock had hit a 52-week high of Rs 796.25 on 28 July 2016 and a 52-week low of Rs 348 on 29 February 2016. The stock had underperformed the market over the past one month till 26 December 2016, declining 8.22% compared with the Sensexs 1.94% fall. The scrip had also underperformed the market over the past one quarter falling 26.26% as against the Sensexs 8.79% fall.

The mid-cap company has equity capital of Rs 97.38 crore. Face value per share is Rs 10.

Capital First said that the meeting of the debenture committee of the board of directors of the company will be held on 29 December 2016, to consider the private placement of rated, listed, secured/unsecured/perpetual, redeemable, non-convertible securities in the nature of debentures.

The debentures shall be listed on the debt market segment of National Stock Exchange of India (NSE).

Capital Firsts consolidated net profit rose 40.3% to Rs 57.57 crore on 57.6% rise in net sales to Rs 686.32 crore in Q2 September 2016 over Q2 September 2015.

Capital First is a leading financial institution in India focused on providing debt financing to micro small and medium enterprises (MSME) and Indian consumers.

Powered by Capital Market - Live News

Future Enterprises moves higher after exiting Future Lifestyle Fashions
Dec 27,2016

Shares of Future Lifestyle Fashions fell 1.24% at Rs 119.10.

Meanwhile, the S&P BSE Sensex was up 121.75 points or 0.47% at 25,928.85.

On the BSE, 29,000 shares of Future Enterprises were traded on the counter so far as against the average daily volumes of 3.39 lakh shares in the past one quarter. The stock had hit a high of Rs 16.85 and a low of Rs 16 so far during the day.

The stock had hit a 52-week high of Rs 28.55 on 26 May 2016 and a 52-week low of Rs 14.20 on 9 November 2016. It had outperformed the market over the past one month till 26 December 2016, sliding 0.62% compared with the Sensexs 1.94% fall. The scrip had also outperformed the market in past one quarter, advancing 0.94% as against the Sensexs 8.79% fall.

The small-cap company has equity capital of Rs 86.64 crore. Face value per share is Rs 2.

Future Enterprises sold 3.05 crore shares of Future Lifestyle Fashions to Future Corporate Resources at Rs 123 per share in a bulk deal on the NSE yesterday, 26 December 2016. With this transaction, Future Enterprises sold off its entire stake of 16.09% in Future Lifestyle Fashions (holding as on 30 September 2016). Future Corporate Resources held 17.04% stake in Future Lifestyle Fashions as on 30 September 2016.

Future Enterprises reported net loss of Rs 33.85 crore in Q2 September 2016 as against net profit of Rs 32.48 crore in Q2 September 2015. Net sales declined 69.3% to Rs 935.25 crore in Q2 September 2016 over Q2 September 2015.

Future Enterprises is into retail infrastructure business after demerging retail business into Bharti Retail.

Powered by Capital Market - Live News

Bharat Financial Inclusion rises on bargain hunting
Dec 27,2016

Meanwhile, the BSE Sensex was up 106.17 points, or 0.41%, to 25,913.27.

On the BSE, so far 6.28 lakh shares were traded in the counter, compared with average daily volumes of 2.75 lakh shares in the past one quarter. The stock had hit a high of Rs 495.60 and a low of Rs 465.40 so far during the day.

The stock hit a 52-week high of Rs 938.75 on 29 July 2016. The stock hit a 52-week low of Rs 435 on 21 January 2016. The stock had underperformed the market over the past 30 days till 26 December 2016, falling 31.29% compared with the 1.94% fall in the Sensex. The scrip had also underperformed the market in past one quarter, falling 43.88% as against Sensexs 8.56% decline.

The mid-cap company has equity capital of Rs 137.93 crore. Face value per share is Rs 10.

Shares of Bharat Financial Inclusion fell 27.15% in seven trading sessions to settle at Rs 480.45 yesterday, 26 December 2016, from its close of Rs 659.55 on 15 December 2016.

Bharat Financial Inclusions net profit rose 87.4% to Rs 145.88 crore on 37.4% increase in operating income to Rs 411.37 crore in Q2 September 2016 over Q2 September 2015.

Bharat Financial Inclusion is among the largest microfinance companies in India.

Powered by Capital Market - Live News

Divis Lab gains on bargain hunting
Dec 27,2016

Meanwhile, the BSE Sensex was up 109.81 points, or 0.43%, to 25,916.91.

On the BSE, so far 2.97 lakh shares were traded in the counter, compared with average daily volumes of 90,758 shares in the past one quarter. The stock had hit a high of Rs 786.50 and a low of Rs 761 so far during the day.

The stock hit a record high of Rs 1,380 on 16 September 2016. The stock hit a 52-week low of Rs 745 on 26 December 2016. The stock had underperformed the market over the past 30 days till 26 December 2016, falling 33.86% compared with the 1.94% fall in the Sensex. The scrip had also underperformed the market in past one quarter, falling 42.20% as against Sensexs 8.56% decline.

The large-cap company has equity capital of Rs 53.09 crore. Face value per share is Rs 2.

Shares of Divis Laboratories fell 33.28% in three trading sessions to settle at Rs 765.30 yesterday, 26 December 2016, from its close of Rs 1,147.10 on 21 December 2016.

The recent slump was triggered by media reports of adverse observations from the US drug regulator made on its Vizag facility in Andhra Pradesh.

Shares of Divis Laboratories slumped 21.87% to Rs 866.10 on Friday, 23 December 2016, following media reports of adverse observations from the US Food and Drug Administration (USFDA) made on its Vizag facility in Andhra Pradesh. Divis Laboratories is in the process of replying to the observations raised by USFDA. Due process of reply to these observations requires Divis Laboratories to respond in detail and this is being done in time, the company said in a response to the clarification sought by the stock exchanges on the steep fall. These observations have not impacted the companys operations, the company added. USFDA inspected the Unit-2 plant from 29 November 2016 to 6 December 2016 and issued a Form 483 with five observations pertaining to breaches in data integrity, improper controls and violations of current good manufacturing practices (cGMP). The company issued the clarification after market hours on Friday, 23 December 2016.

The stock fell 30.97% in two trading sessions to settle at Rs 765.30 yesterday, 26 December 2016, from its close of Rs 1,108.60 on Thursday, 22 December 2016.

Divis Laboratories net profit fell 24.6% to Rs 223.85 crore on 3.11% growth in net sales to Rs 991.82 crore in Q2 September 2016 over Q2 September 2015.

Divis Laboratories is primarily engaged in the manufacture of active pharmaceutical ingredients (APIs) & intermediates for generics, custom synthesis of APIs and advanced intermediates for discovery compounds for pharma giants, building blocks for peptides, building blocks for nucleotides, carotenoids and chiral ligands.

Powered by Capital Market - Live News

D-Link (India) moves north on fund buying
Dec 27,2016

Meanwhile, the S&P BSE Sensex was up 94.43 points or 0.37% at 25,901.53.

On the BSE, 37,000 shares were traded on the counter so far as against the average daily volumes of 1.09 lakh shares in the past one quarter. The stock had hit a high of Rs 109.80 and a low of Rs 107.95 so far during the day.

The stock had hit a 52-week high of Rs 181 on 1 January 2016 and a 52-week low of Rs 75.25 on 21 September 2016. It had outperformed the market over the past one month till 26 December 2016, surging 29% compared with the Sensexs 1.94% fall. The scrip had also outperformed the market in past one quarter, advancing 22.68% as against the Sensexs 8.79% fall.

The small-cap company has equity capital of Rs 7.10 crore. Face value per share is Rs 2.

D-Link (India)s net profit rose 107% to Rs 7.12 crore on 16.6% growth in net sales to Rs 201.79 crore in Q2 September 2016 over Q2 September 2015.

D-Link is engaged in the design, manufacture and marketing of advanced networking, broadband, digital, voice and data communications solutions.

Powered by Capital Market - Live News

Glenmark Pharma gains after USFDA approval for Tretinoin capsules
Dec 27,2016

The announcement was made during trading hours today, 27 December 2016.

Meanwhile, the BSE Sensex was up 70.88 points, or 0.27%, to 25,877.98.

On the BSE, so far 11,000 shares were traded in the counter, compared with average daily volumes of 58,492 shares in the past one quarter. The stock had hit a high of Rs 900.95 and a low of Rs 883.50 so far during the day.

The stock hit a 52-week high of Rs 993 on 1 November 2016. The stock hit a 52-week low of Rs 671.50 on 12 February 2016.

Glenmark Pharmaceuticals Inc., USA (Glenmark) received final approval from the United States Food & Drug Administration (USFDA) for Tretinoin capsules, 10 milligrams (mg), the generic version of Vesanoid capsules, 10 mg, of Hoffmann La Roche, Inc. (which is no longer being marketed in the United States).n++n++

According to IMS Health sales data for the 12 month period ending October 2016, the Vesanoid Capsules, 10 mg market achieved annual sales of approximately $22 million.

n++n++Glenmarks current portfolio consists of 112 products authorized for distribution in the US marketplace and 63 abbreviated new drug application (ANDA)s pending approval with the USFDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.n++n++

On a consolidated basis, Glenmark Pharmaceuticals net profit rose 3.46% to Rs 223.59 crore on 15.67% rise in net sales to Rs 2173.18 crore in Q2 September 2016 over Q2 September 2015.

Glenmark Pharmaceuticals is a research‐driven, global, integrated pharmaceutical organization headquartered at Mumbai, India.

Powered by Capital Market - Live News

Deepak Nitrite recovers on bargain hunting
Dec 27,2016

Meanwhile, the S&P BSE Sensex was up 27.09 points or 0.1% at 25,834.19.

On the BSE, 2,917 shares were traded on the counter so far as against the average daily volumes of 61,111 shares in the past one quarter. The stock had hit a high of Rs 83.55 and a low of Rs 82.10 so far during the day.

The stock had hit a record high of Rs 134.25 on 9 September 2016 and a 52-week low of Rs 56.10 on 12 February 2016. It had underperformed the market over the past one month till 26 December 2016, sliding 12.67% compared with the Sensexs 1.94% fall. The scrip had also underperformed the market in past one quarter, declining 30.78% as against the Sensexs 8.79% fall.

The small-cap company has equity capital of Rs 23.26 crore. Face value per share is Rs 2.

Shares of Deepak Nitrite tumbled 17.6% in the preceding seven straight trading sessions to settle at Rs 81.65 yesterday, 26 December 2016, from its close of Rs 99.10 on 15 December 2016.

In a recent development on the counter, Quest Investment Advisors on 23 December 2016 sold 35.35 lakh shares of Deepak Nitrite at an average price of Rs 85.12 per share in bulk deals on the NSE. Reliance Mutual Fund-Reliance Small Cap Fund bought 35.73 lakh shares at Rs 85.06 a piece. Quest is an investment management services firm.

Deepak Nitrites net profit rose 4.3% to Rs 15.41 crore on 10.6% decline in net sales to Rs 299.07 crore in Q2 September 2016 over Q2 September 2015.

Deepak Nitrite is a multi-division and multi-product company. The companys portfolio is a wide spectrum of products with diverse applications ranging from agrochemicals, rubber, pharmaceuticals, paper, textile, detergent, colourants, petrochemicals to speciality and fine chemicals.

Powered by Capital Market - Live News

Empee Distilleries slips after board withdraws proposed sale of shares in Empee Hotels
Dec 27,2016

The announcement was made after market hours yesterday, 26 December 2016.

Meanwhile, the BSE Sensex was up 42.72 points, or 0.17%, to 25,849.82.

On the BSE, so far 1,935 shares were traded in the counter, compared with average daily volumes of 36,729 shares in the past one quarter. The stock had hit a high of Rs 51.25 and a low of Rs 50.60 so far during the day.

The stock hit a 52-week high of Rs 105.65 on 4 January 2016. The stock hit a 52-week low of Rs 44.50 on 22 November 2016. The stock had outperformed the market over the past 30 days till 26 December 2016, falling 0.58% compared with the 1.94% fall in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 27.29% as against Sensexs 8.56% decline.

The small-cap company has equity capital of Rs 19.01 crore. Face value per share is Rs 10.

The board of directors of Empee Distilleries in the meeting held yesterday, 26 December 2016, called off the proposed sale of 1.95 crore equity shares of Rs 10 each held by the company in Empee Hotels, an unlisted entity.

Empee Distilleries reported net loss of Rs 5.92 crore in Q2 September 2016 as against net profit of Rs 4.91 crore in Q2 September 2015. Net sales declined 30.9% to Rs 121.03 crore in Q2 September 2016 over Q2 September 2015.

Empee Distilleries principal activity is manufacture and sale of Indian made foreign liquor.

Powered by Capital Market - Live News

InterGlobe Aviation drops amid volatility
Dec 26,2016

Meanwhile, the S&P BSE Sensex was down 237.95 points or 0.91% at 25,802.75.

On the BSE, 15,000 shares were traded on the counter so far as against the average daily volumes of 32,556 shares in the past one quarter. The stock was volatile. The stock lost as much as 0.43% at the days low of Rs 820.35 so far during the day. The stock rose as much as 1.93% at the days high of Rs 839.90 so far during the day.

The stock had hit a record high of Rs 1,395.50 on 1 January 2016 and a 52-week low of Rs 702 on 11 February 2016. It had underperformed the market over the past one month till 23 December 2016, sliding 5.17% compared with the Sensexs 0.04% fall. The scrip had also underperformed the market in past one quarter, declining 10.67% as against the Sensexs 9.17% fall.

The large-cap company has equity capital of Rs 364.58 crore. Face value per share is Rs 10.

As per media reports, few overseas investment firms are competing to acquire a controlling stake in InterGlobe Technology Quotient, the travel reservation arm of InterGlobe Enterprises that runs IndiGo Airlines.

InterGlobe Enterprises is parent company of InterGlobe Aviation. It owned 42.51% in InterGlobe Aviation end September 2016.

InterGlobe Aviations net profit rose 23.6% to Rs 139.85 crore on 17.9% growth in net sales to Rs 4149.30 crore in Q2 September 2016 over Q2 September 2015.

InterGlobe Aviation is the operator of low cost passenger airline IndiGo

Powered by Capital Market - Live News

Balkrishna Industries gains on bargain hunting
Dec 26,2016

Meanwhile, the BSE Sensex was down 242.53 points, or 0.93%, to 25,798.17.

On the BSE, so far 5,272 shares were traded in the counter, compared with average daily volumes of 18,558 shares in the past one quarter. The stock had hit a high of Rs 1,086.80 and a low of Rs 1,030 so far during the day.

The stock hit a 52-week high of Rs 1,280 on 2 December 2016. The stock hit a 52-week low of Rs 551.35 on 26 February 2016. The stock had outperformed the market over the past 30 days till 23 December 2016, rising 13.65% compared with the 0.70% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 23.51% as against Sensexs 9.17% decline.

The large-cap company has equity capital of Rs 19.33 crore. Face value per share is Rs 2.

Shares of Balkrishna Industries fell 7.22% in four trading sessions to settle at Rs 1,051.30 yesterday, 23 December 2016, from its close of Rs 1,133.05 on 19 December 2016.

Net profit of Balkrishna Industries rose 128.67% to Rs 242.92 crore on 14% rise in net sales to Rs 912.15 crore in Q2 September 2016 over Q2 September 2015.

Balkrishna Industries is a leading manufacturer in the off-highway tire market. The company has focused on specialist segments such as agricultural, construction and industrial vehicles as well as earthmoving, port and mining, ATV, and gardening applications.

Powered by Capital Market - Live News

Den Networks jumps on bargain hunting
Dec 26,2016

Meanwhile, the BSE Sensex was down 207.85 points, or 0.80%, to 25,832.85.

On the BSE, so far 1.39 lakh shares were traded in the counter, compared with average daily volumes of 51,272 shares in the past one quarter. The stock had hit a high of Rs 71 and a low of Rs 63.05 so far during the day.

The stock hit a 52-week high of Rs 116 on 30 December 2015. The stock hit a 52-week low of Rs 60.50 on 15 February 2016. The stock had underperformed the market over the past 30 days till 23 December 2016, falling 5.78% compared with the 0.70% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 20.36% as against Sensexs 9.17% decline.

The small-cap company has equity capital of Rs 194.03 crore. Face value per share is Rs 10.

Shares of Den Networks fell 14.60% in eight trading sessions to settle at Rs 64.35 on Friday, 23 December 2016, from its close of Rs 75.35 on 13 December 2016.

Den Networks reported net loss of Rs 47.87 crore in Q2 September 2016 as against net loss of Rs 97.76 crore in Q2 September 2015. Net sales rose 20.85% to Rs 257.30 crore in Q2 September 2016 over Q2 September 2015.

Den Networks is Indias leading cable TV distribution company reaching an estimated 13 million households in over 200 cities across 13 key states in India.

Powered by Capital Market - Live News

Sasken Comm slips after fixing buyback terms
Dec 26,2016

Meanwhile, the S&P BSE Sensex was down 157.59 points or 0.61% at 25,883.11.

On the BSE, 6,164 shares were traded on the counter so far as against the average daily volumes of 8,650 shares in the past one quarter. The stock had hit a high of Rs 410 and a low of Rs 392.25 so far during the day.

The stock had hit a 52-week high of Rs 448.40 on 21 December 2016 and a 52-week low of Rs 233.10 on 29 February 2016. It had outperformed the market over the past one month till 23 December 2016, advancing 8.18% compared with the Sensexs 0.04% fall. The scrip had also outperformed the market in past one quarter, surging 17.78% as against the Sensexs 9.17% fall.

The small-cap company has equity capital of Rs 17.72 crore. Face value per share is Rs 10.

Sasken Communication Technologies on Saturday, 24 December 2016 announced to the exchanges that the buyback committee of the board of directors, at its meeting held on Friday, 23 December 2016, fixed the buyback price of Rs 410 per share and the total consideration for buyback at Rs 120.04 crore excluding the transaction costs. This represents 16.52% of the total issued and paid-up equity share capital of the company as on 31 March 2016.

Sasken Communication Technologies consolidated net profit fell 9.2% to Rs 9.58 crore on 7.4% decline in net sales to Rs 118.40 crore in Q2 September 2016 over Q2 September 2015.

Sasken Communication Technologies is a leader in providing engineering R&D and productized IT services to global tier I customers in the communications & devices, retail, insurance and independent software space.

Powered by Capital Market - Live News